We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$634M
AUM Growth
+$37.2M
Cap. Flow
+$2.67M
Cap. Flow %
0.42%
Top 10 Hldgs %
58.75%
Holding
411
New
33
Increased
61
Reduced
34
Closed
10
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESGV icon
176
Vanguard ESG US Stock ETF
ESGV
$13.6B
$40K 0.01%
391
EZU icon
177
iShare MSCI Eurozone ETF
EZU
$9.91B
$39K 0.01%
738
BURL icon
178
Burlington
BURL
$23.2B
$38K 0.01%
143
MRK icon
179
Merck
MRK
$318B
$37K 0.01%
326
IAU icon
180
iShares Gold Trust
IAU
$67.5B
$36K 0.01%
729
SCHG icon
181
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
$35K 0.01%
1,356
IWP icon
182
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$34K 0.01%
286
AVGO icon
183
Broadcom
AVGO
$2.04T
$33K 0.01%
190
BLK icon
184
Blackrock
BLK
$176B
$33K 0.01%
35
CLF icon
185
Cleveland-Cliffs
CLF
$6.99B
$33K 0.01%
2,561
MCHP icon
186
Microchip Technology
MCHP
$46B
$33K 0.01%
408
AMP icon
187
Ameriprise Financial
AMP
$48.8B
$32K 0.01%
69
CHD icon
188
Church & Dwight Co
CHD
$24.5B
$31K ﹤0.01%
300
UL icon
189
Unilever
UL
$136B
$31K ﹤0.01%
427
VSGX icon
190
Vanguard ESG International Stock ETF
VSGX
$6.74B
$31K ﹤0.01%
509
APD icon
191
Air Products & Chemicals
APD
$67.6B
$30K ﹤0.01%
100
NOC icon
192
Northrop Grumman
NOC
$81.2B
$29K ﹤0.01%
54
GSK icon
193
GSK
GSK
$106B
$28K ﹤0.01%
685
-2,160
-76% -$88.4K
MAR icon
194
Marriott International
MAR
$92.3B
$26K ﹤0.01%
104
T icon
195
AT&T
T
$163B
$26K ﹤0.01%
1,201
+6
+0.5% +$119
VGT icon
196
Vanguard Information Technology ETF
VGT
$149B
$25K ﹤0.01%
336
AZN icon
197
AstraZeneca
AZN
$250B
$24K ﹤0.01%
157
WD icon
198
Walker & Dunlop
WD
$1.53B
$23K ﹤0.01%
199
APO icon
199
Apollo Global Management
APO
$73.4B
$22K ﹤0.01%
176
CME icon
200
CME Group
CME
$94.8B
$22K ﹤0.01%
100

Similar funds

Roble Belko & Company's Q3 2024 Portfolio in Review

As of Q3 2024, Roble Belko & Company held 411 positions worth $634M, up 6.2% from $597M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Roble Belko & Company's Q3 2024 filing shows 33 new, 61 increased, 34 reduced and 10 closed positions. Its largest new stake was PPL Corp: 2,908 shares worth $96K. The largest sale was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, an estimated $2.05M.

By sector, the portfolio is most concentrated in Technology at 1.9% of assets, down from 2% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Roble Belko & Company's largest Q3 2024 buy was PPL Corp: 2,908 shares worth $96K.
  • Roble Belko & Company added most to Schwab International Equity ETF in Q3 2024, an estimated $4.3M increase.
  • Roble Belko & Company's biggest Q3 2024 reduction was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, cutting an estimated $2.05M.
  • Roble Belko & Company fully exited Harley-Davidson in Q3 2024, selling an estimated $268K.
  • Roble Belko & Company's ten largest holdings make up 59% of its $634M portfolio in Q3 2024.
  • Roble Belko & Company opened 33 new positions and closed 10 in Q3 2024.
  • Roble Belko & Company's portfolio value rose 6.2% quarter-over-quarter to $634M.

Based on Roble Belko & Company's 13F filing for Q3 2024, filed 15 Oct 2024.